Health Plan Group Puts Biosimilars On Its Roadmap of Needed Healthcare Reforms

September 28th 2020

The Alliance of Community Health Plans calls for changes to get more biosimilars approved and on the market.

Proliferation of Biosimilars Could Be Costly for Oncologists, Warns Texas Oncology Policy Leader

September 28th 2020

Texas Oncology Executive Vice President Debra Patt says it will be unrealistically expensive for oncologists to keep many biosimilars for the same innovator product in their inventories.

Benefits of an Over-The-Phone Physical Exam

September 27th 2020

Those who have avoided visiting or put off their annual physical appointments at the doctor's office due to fears of contracting COVID-19 do not have put off those appointments any longer.

FDA Updates: Approval to Treat Rare Blood Disorders; Label Change for Benzodiazepines

September 27th 2020

Approval for treatment of HES, update to address addictive nature of benzodiazepines.

How the Healthcare Industry, Worker Roles will Evolve as a Result of COVID-19

September 26th 2020

The coronavirus pandemic has shed light on major imbalances within the healthcare system, specifically, the supply and demand of allied health professionals, and the urgent need to invest in community-based care that prioritizes vulnerable populations.

Hospital Finances, Patient Volumes Took A Step Back in August

September 25, 2020

After three months of recovery, financial and volume indicators were off in August, according to Kaufman Halls's monthly report.

Medicare Advantage Star Ratings: The New Patient Experience Imperative for Health Plans

September 25, 2020

CMS is putting more weight on patient experience measures in its Medicare Advantage and Part D Star ratings. What health plans can do now to improve their ratings.

5 Changes That Should be Made in Oncology

September 25, 2020

COVID-19 is certainly important. But oncologists, people with cancer, and complex ecosystem of cancer care in the U.S. are grappling with other important issues such as reimbursement, distorted incentives, the implications of the massive amount of data that is available, and, of course, high costs and prices. Included are thoughts from five experts on these challenges and how they might be met.

Medicare Advantage Enrollment Increasing By 10.2% Next Year

September 25, 2020

CMS says 26.9 million beneficiaries are expected to enroll in Medicare Advantage plans in 2021.

CMS Launching Efforts To Transform Ambulance Services

September 24, 2020

CMS is taking prior authorization for frequent, non-emergency ambulance transportation nationwide and launching a model that pay ambulance services for taking patients to nonhospital facilities.